Stockscreener 앱 받기
23.88
0.99%
0.23
전일 마감가:
$23.65
열려 있는:
$23.85
하루 거래량:
681.55K
Relative Volume:
0.19
시가총액:
$1.92B
수익:
-
순이익/손실:
$-96.66M
주가수익비율:
-11.11
EPS:
-2.15
순현금흐름:
$-83.73M
1주 성능:
-4.50%
1개월 성능:
-17.04%
6개월 성능:
+349.81%
1년 성능:
+383.50%
1일 변동 폭
$22.79
$24.18
1주일 범위
$22.40
$26.48
52주 변동 폭
$2.86
$36.26
올레마 Stock (OLMA) Company Profile
명칭
Olema Pharmaceuticals Inc
전화
(415) 651-3316
주소
780 BRANNAN STREET, SAN FRANCISCO
Compare OLMA vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
23.91 | 1.90B | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
464.26 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
790.78 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
835.51 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
309.11 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.23 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
올레마 Stock (OLMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-11 | 개시 | Stifel | Buy |
| 2026-01-07 | 개시 | Piper Sandler | Overweight |
| 2025-10-08 | 개시 | Guggenheim | Buy |
| 2025-08-12 | 재확인 | Citigroup | Buy |
| 2024-04-02 | 개시 | Goldman | Buy |
| 2024-01-30 | 개시 | Citigroup | Buy |
| 2023-07-21 | 개시 | Oppenheimer | Outperform |
| 2023-05-05 | 개시 | CapitalOne | Overweight |
| 2023-02-22 | 개시 | Credit Suisse | Outperform |
| 2022-07-06 | 재개 | Canaccord Genuity | Buy |
| 2022-06-09 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | 개시 | H.C. Wainwright | Neutral |
| 2021-12-07 | 재개 | Cowen | Outperform |
| 2020-12-14 | 개시 | Canaccord Genuity | Buy |
| 2020-12-14 | 개시 | Cowen | Outperform |
| 2020-12-14 | 개시 | JP Morgan | Overweight |
| 2020-12-14 | 개시 | Jefferies | Buy |
모두보기
올레마 주식(OLMA)의 최신 뉴스
This Olema Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday - Benzinga
Stifel Initiates Coverage on Olema Pharmaceuticals (OLMA) with B - GuruFocus
Olema Pharmaceuticals (NASDAQ:OLMA) Now Covered by Analysts at Stifel Nicolaus - MarketBeat
Stifel Nicolaus Initiates Coverage on Olema Pharmaceuticals With Buy Rating - marketscreener.com
Candriam S.C.A. Increases Stock Position in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Will Olema Pharmaceuticals Inc. stock benefit from automationJuly 2025 Closing Moves & Weekly High Return Stock Opportunities - mfd.ru
Stifel initiates Olema Pharmaceuticals stock with Buy rating, $48 target By Investing.com - Investing.com Canada
Olema Pharmaceuticals, Inc. Rings the Closing Bell - Nasdaq
Olema Oncology to Participate in Upcoming Investor Conferences - Sahm
Olema Pharmaceuticals seeks NDA lead for biotech program - Traders Union
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Weekly Recap: Does Olema Pharmaceuticals Inc have pricing power2025 Key Highlights & High Conviction Trade Alerts - baoquankhu1.vn
Institutional Investors Control 63% of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) and Were Rewarded Last Week After Stock Increased 7.2% - 富途牛牛
Cancer index surges 72% as Terns, Olema lead gains - BioWorld MedTech
Investment Review: Is Olema Pharmaceuticals Inc stock trending bullishQuarterly Trade Summary & Consistent Return Strategy Ideas - baoquankhu1.vn
Olema Pharmaceuticals to Present at Upcoming Investor Conferences in February 2026 - Quiver Quantitative
Breast cancer drug developer Olema lines up three investor talks - Stock Titan
Risks Report: Whats next for Olema Pharmaceuticals Inc stockJuly 2025 Setups & Growth Focused Investment Plans - baoquankhu1.vn
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Short Interest in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Decreases By 12.5% - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Shares Gap DownTime to Sell? - MarketBeat
A Look At Olema Pharmaceuticals (OLMA) Valuation After Renewed Buy Ratings And Phase 3 Breast Cancer Plans - Sahm
Breakout Zone: How much upside does Olema Pharmaceuticals Inc haveJuly 2025 Market Mood & Accurate Buy Signal Alerts - baoquankhu1.vn
Trend Recap: What are analysts price targets for Olema Pharmaceuticals IncEarnings Miss & Fast Moving Stock Watchlists - baoquankhu1.vn
Olema Oncology CFO Shane Kovacs to depart after six-year tenure By Investing.com - Investing.com India
Olema CFO Exit Puts Focus On Palazestrant Plans And Cash Discipline - Yahoo Finance
Olema Oncology CFO Shane Kovacs to depart after six-year tenure - Investing.com Australia
Olema Pharmaceuticals CFO Shane Kovacs departs, CEO assumes interim finance role By Investing.com - Investing.com Nigeria
Olema Pharmaceuticals CFO Shane Kovacs departs, CEO assumes interim finance role - Investing.com Nigeria
Olema Pharmaceuticals stock falls after CFO announces departure By Investing.com - Investing.com South Africa
Olema Pharmaceuticals stock falls after CFO announces departure - Investing.com
Olema Pharmaceuticals (OLMA) Executive Leadership Shift - GuruFocus
Olema Pharmaceuticals CFO Departs; CEO Assumes Interim Role - TipRanks
Olema Pharmaceuticals Chief Operating and Financial Officer Shane Kovacs Departs - marketscreener.com
Olema Oncology Announces Departure of Chief Operating and Financial Officer - The Manila Times
Olema (NASDAQ: OLMA) CFO exits with $621,283 package as CEO steps in - Stock Titan
Olema Oncology announces departure of chief operating and financial officer - marketscreener.com
Breast cancer-focused Olema sees financial officer depart, CEO steps in - stocktitan.net
LifeSci Capital Reiterates a Buy on Olema Pharmaceuticals (OLMA) - Finviz
10 Best Small-Cap Stocks Ready to Explode in 2026 - Insider Monkey
Olema Pharmaceuticals (OLMA) stock jumps 6% in a weak market — what to watch next - TechStock²
Olema Pharmaceuticals (NASDAQ:OLMA) Trading 7.7% HigherHere's What Happened - MarketBeat
Should I invest in Olema Pharmaceuticals Inc. before earningsGap Down & High Conviction Trade Alerts - mfd.ru
SEC Enforcement Action Targets Insider Trading in the Pharmaceutical Industry - akingump.com
Aug Outlook: Does Olema Pharmaceuticals Inc have pricing power2025 Geopolitical Influence & High Conviction Trade Alerts - baoquankhu1.vn
Apellis, Olema, Exicure, Immunovant, LivePerson Insider Shake-Up - TipRanks
Harmon Cyrus, director at Olema, sells $268,800 in stock By Investing.com - Investing.com UK
Olema Pharmaceuticals (NASDAQ:OLMA) Director Cyrus Harmon Sells 10,000 Shares - MarketBeat
Harmon Cyrus, director at Olema, sells $268,800 in stock - Investing.com
올레마 (OLMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.06%
2.21%
자본화:
|
볼륨(24시간):